Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03554759 |
|
Recruitment Status :
Terminated
(Study was terminated early due to enrollment challenges)
First Posted : June 13, 2018
Last Update Posted : March 8, 2019
|
Sponsor:
Sobi, Inc.
Information provided by (Responsible Party):
Sobi, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 31, 2019 |
| Actual Study Completion Date : | January 31, 2019 |